Loading company…
Winston-Salem-based biopharmaceutical company developing therapies for central nervous system disorders.
Targacept, founded in 1997 in Winston-Salem, US, is a biopharmaceutical company developing innovative therapies for central nervous system disorders, including depression and cognitive impairment. The company went public in April 2006, raising USD 45 mn through an IPO. In March 2015 it announced a merger with Catalyst Biosciences, which would form a new entity named Catalyst Biosciences, Inc.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in